Updated on 2024/12/14

写真a

 
FUJII Yumiko
 
Organization
School of Medicine Medical Course Basic Medicine Pathology[Tumor Pathology]
External link

Degree

  • 博士(理学) ( 北海道大学 )

Research History

  • Asahikawa Medical College   School of Medicine   Assistant Professor

    2019.7

      More details

  • The University of Tokyo   Graduate School of Medicine

    2014.4 - 2019.6

      More details

  • Max Planck-The University of Tokyo Center for Integrative Inflammology,   Junior Fellow

    2014.4 - 2019.3

      More details

  • The University of Tokyo   Graduate School of Medicine

    2013.4 - 2014.3

      More details

  • Hokkaido University   Graduate School of Science, Department of Chemistry

    2013.3

      More details

Professional Memberships

Papers

  • Tumor-educated plateletsの蛋白質合成能の増強による肝発がん促進

    田中 宏樹, 堀岡 希衣, 後藤 正憲, 藤井 裕美子, 上小倉 佑機, 小川 勝洋, 西川 祐司

    日本病理学会会誌   112 ( 1 )   259 - 259   2023.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • High levels of Myc expression are required for the robust proliferation of hepatocytes, but not for the sustained weak proliferation. International journal

    Masanori Goto, Takako Ooshio, Masahiro Yamamoto, Hiroki Tanaka, Yumiko Fujii, Lingtong Meng, Yuki Kamikokura, Yoko Okada, Yuji Nishikawa

    Biochimica et biophysica acta. Molecular basis of disease   1869 ( 4 )   166644 - 166644   2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In contrast to the robust proliferation exhibited following acute liver injury, hepatocytes exhibit long-lasting proliferative activity in chronic liver injury. The mechanistic differences between these distinct modes of proliferation are unclear. Hepatocytes exhibited robust proliferation that peaked at 2 days following partial hepatectomy in mice, but this proliferation was completely inhibited by hepatocyte-specific expression of MadMyc, a Myc-suppressing chimeric protein. However, Myc suppression induced weak but continuous hepatocyte proliferation, thereby resulting in full restoration of liver mass despite an initial delay. Late-occurring proliferation was accompanied by prolonged suppression of proline dehydrogenase (PRODH) expression, and forced PRODH overexpression inhibited hepatocyte proliferation. In hepatocytes in chronic liver injury, Myc was not activated but PRODH expression was suppressed in regenerating hepatocytes. In liver tumors, PRODH expression was often suppressed, especially in the highly proliferative tumors with distinct Myc expression. Our results indicate that the robust proliferation of hepatocytes following acute liver injury requires high levels Myc expression and that there is a compensatory Myc-independent mode of hepatocyte proliferation with the regulation of proline metabolism, which might be relevant to liver regeneration in chronic injury.

    DOI: 10.1016/j.bbadis.2023.166644

    PubMed

    researchmap

  • Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor-platelet interactions. International journal

    Hiroki Tanaka, Kie Horioka, Takumu Hasebe, Koji Sawada, Shunsuke Nakajima, Hiroaki Konishi, Shotaro Isozaki, Masanori Goto, Yumiko Fujii, Yuki Kamikokura, Katsuhiro Ogawa, Yuji Nishikawa

    International journal of cancer   150 ( 10 )   1640 - 1653   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Hepatocellular carcinoma (HCC) activates platelets through the action of adjacent sinusoidal cells. Activated platelets bind to tumor-associated endothelial cells and release growth factors that promote tumor progression. We hypothesized that platelets encapsulated with tumor inhibitors would function as drug carriers for tumor therapy. We propose a therapeutic strategy for HCC using autologous platelets encapsulating multiple tyrosine kinase inhibitors in a rat chemically induced HCC model. Sorafenib or lenvatinib was encapsulated in platelets isolated from tumor-bearing rats in vitro. The rats were divided into groups that received repeated intravenous injections (twice a week for 10 weeks) of the following materials: placebo, sorafenib (SOR), lenvatinib (LEN), autologous platelets, autologous platelets encapsulating sorafenib (SOR-PLT) and autologous platelets encapsulating lenvatinib (LEN-PLT). The therapeutic effect was then analyzed by ultrasonography (US) and histopathological analysis. Histopathological and US analysis demonstrated extensive tumor necrosis in the tumor tissue of SOR-PLT or LEN-PLT, but not in other experimental groups. By liquid chromatography-mass spectrometry, more abundant sorafenib was detected in tumor tissues after SOR-PLT administration than in surrounding normal tissues, but no such difference in sorafenib level was observed with SOR administration. Therefore, the use of autologous platelets encapsulating drugs might be a novel therapeutic strategy for HCC.

    DOI: 10.1002/ijc.33915

    PubMed

    researchmap

  • 自己血小板を用いたドラッグデリバリーシステムの肝細胞癌に対するターゲティング効果

    田中 宏樹, 堀岡 希衣, 後藤 正憲, 人見 淳一, 藤井 裕美子, 上小倉 佑機, 孟 玲童, 小川 勝洋, 西川 祐司

    日本癌学会総会記事   80回   [J14 - 5]   2021.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • Decreased Portal Circulation Augments Fibrosis and Ductular Reaction in Nonalcoholic Fatty Liver Disease in Mice Reviewed International journal

    Lingtong Meng, Masanori Goto, Hiroki Tanaka, Yuki Kamikokura, Yumiko Fujii, Yoko Okada, Hiroyuki Furukawa, Yuji Nishikawa

    The American Journal of Pathology   191 ( 9 )   1580 - 1591   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Nonalcoholic fatty liver disease often progresses to cirrhosis and causes liver cancer, but mechanisms of its progression have not been elucidated. Although nonalcoholic fatty liver disease is often associated with abnormal portal circulation, there have not been any experimental studies to test its pathogenic role. Here, whether decreased portal circulation affected the pathology of nonalcoholic steatohepatitis (NASH) was examined using congenital portosystemic shunt (PSS) in C57BL/6J mice. Whereas PSS significantly attenuated free radical-mediated carbon tetrachloride injury, it augmented pericellular fibrosis in the centrilobular area induced by a 0.1% methionine choline-deficient l-amino acid-defined high-fat diet (CDAHFD). PSS aggravated ductular reaction and increased the expression of connective tissue growth factor. Pimonidazole immunohistochemistry of the liver revealed that the centrilobular area of PSS-harboring mice was more hypoxic than that of control mice. Although tissue hypoxia was observed in the fibrotic area in CDAHFD-induced NASH in both control and PSS-harboring mice, it was more profound in the latter, which was associated with higher carbonic anhydrase 9 and vascular endothelial growth factor expression and neovascularization in the fibrotic area. Furthermore, partial ligation of the portal vein also augmented pericellular fibrosis and ductular reaction induced by a CDAHFD. These results demonstrate that decreased portal circulation, which induces hypoxia due to disrupted intralobular perfusion, is an important aggravating factor of liver fibrosis in NASH.

    DOI: 10.1016/j.ajpath.2021.06.001

    PubMed

    researchmap

▼display all

MISC

  • 自己血小板を用いたドラッグデリバリーシステムの肝細胞癌に対するターゲティング効果

    田中 宏樹, 堀岡 希衣, 後藤 正憲, 人見 淳一, 藤井 裕美子, 上小倉 佑機, 孟 玲童, 小川 勝洋, 西川 祐司

    日本癌学会総会記事   80回   [J14 - 5]   2021.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 自己血小板を利用したドラッグデリバリーシステム 肝癌・血小板相互作用を利用した新たな治療戦略

    田中 宏樹, 堀岡 希衣, 後藤 正憲, 人見 淳一, 藤井 裕美子, 上小倉 佑機, 孟 玲童, 小川 勝洋, 西川 祐司

    日本病理学会会誌   110 ( 1 )   224 - 224   2021.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 腫瘍・血小板相互作用を利用した肝癌に対する新規治療法

    田中 宏樹, 堀岡 希衣, 後藤 正憲, 人見 淳一, 藤井 裕美子, 上小倉 佑機, 孟 玲童, 小川 勝洋, 西川 祐司

    日本癌学会総会記事   79回   PE16 - 3   2020.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • Myc非依存性の肝細胞再生性増殖におけるプロリン代謝の意義

    後藤 正憲, 大塩 貴子, 山本 雅大, 人見 淳一, 藤井 裕美子, 田中 宏樹, 上小倉 佑機, 孟 玲童, 岡田 陽子, 西川 祐司

    日本癌学会総会記事   79回   OJ13 - 4   2020.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • HELICOBACTER PYLORI CAGA DIRECTS GASTRIC INTESTINAL METAPLASIA BY INDUCING STEMNESS-RELATED REPROGRAMMING FACTORS

    M. Hatakeyama, Y. Fujii

    HELICOBACTER   18   79 - 79   2013.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY-BLACKWELL  

    Web of Science

    researchmap

▼display all

Presentations

  • Helicobacter pylori CagA interacts with the lipid phosphatase SHIP2 to increase its delivery into gastric cells

    藤井裕美子

    第79回日本癌学会学術総会  2020.10 

     More details

    Event date: 2020.10

    researchmap

  • ヒト胃上皮細胞における転写因子CDX1異所性発現の意義

    藤井 裕美子

    日本分子生物学会 第8回春季シンポジウム  2008.5 

     More details

    Presentation type:Poster presentation  

    researchmap

  • The role of aberrantly expressed CDX1 transcription factor in gastric epithelial cells

    FUJII Yumiko

    29th International Symposium on Cancer  2009.7 

     More details

    Presentation type:Poster presentation  

    researchmap

  • The effect of CDX1 transcription factor on human gastric epithelial cells

    FUJII Yumiko

    2008.10 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • Helicobacter pylori CagA-induced alterations of E-cadherin modifications

    FUJII Yumiko

    The 37th Sapporo International Cancer Symposium  2018.7 

     More details

    Presentation type:Poster presentation  

    researchmap

▼display all

Research Projects

  • 胆管上皮細胞におけるSHIP2脂質ホスファターゼの核内機能とその発がんへの関与

    Grant number:22K07976  2022.4 - 2025.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    藤井 裕美子

      More details

    Grant amount:\4,290,000 ( Direct Cost: \3,300,000 、 Indirect Cost:\990,000 )

    researchmap

  • 非アルコール性脂肪性肝炎を起点とした肝細胞の多段階発がんメカニズムの解明

    2020.7 - 2021.3

    秋山記念生命科学振興財団  研究助成(奨励) 

      More details

  • Mechanisms determining the wide spectrum of hepatocytic tumors

    Grant number:19H03448  2019.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17,160,000 ( Direct Cost: \13,200,000 、 Indirect Cost:\3,960,000 )

    researchmap

  • ピロリ菌病原因子CagAの宿主細胞内新規結合ホスファターゼの解析

    2019.4 - 2022.3

    日本学術振興会 科学研究費  基盤研究(C) 

    藤井裕美子

      More details

    Authorship:Principal investigator 

    researchmap

  • ピロリ菌病原因子CagAによるE-cadherin脱リン酸化と発がんへの関与

    2017.4 - 2019.3

    日本学術振興会 科学研究費  若手研究(B) 

    藤井 裕美子

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

▼display all